Matches in SemOpenAlex for { <https://semopenalex.org/work/W1998429087> ?p ?o ?g. }
- W1998429087 endingPage "171" @default.
- W1998429087 startingPage "167" @default.
- W1998429087 abstract "The NMDA glutamate hypofunction model of schizophrenia is based in part upon acute effects of NMDA receptor blockade in humans and rodents. Several laboratories have reported glutamate system abnormalities following prenatal exposure to immune challenge, a known environmental risk factor for schizophrenia. Here we report indices of NMDA glutamate receptor hypofunction following prenatal immune activation, as well as the effects of treatment during periadolescence with the atypical antipsychotic medications risperidone and paliperidone. Pregnant Sprague-Dawley rats were injected with polyinosinic:polycytidylic acid (poly I:C) or saline on gestational day 14. Male offspring were treated orally via drinking water with vehicle, risperidone (0.01mg/kg/day), or paliperidone (0.01mg/kg/day) between postnatal days 35 and 56 (periadolescence) and extracellular glutamate levels in the prefrontal cortex were determined by microdialysis at PD 56. Consistent with decreased NMDA receptor function, MK-801-induced increases in extracellular glutamate concentration were markedly blunted following prenatal immune activation. Further suggesting NMDA receptor hypofunction, prefrontal cortex basal extracellular glutamate was significantly elevated (p<0.05) in offspring of poly I:C treated dams. Pretreatment with low dose paliperidone or risperidone (0.01mg/kg/day postnatal days 35-56) normalized prefrontal cortical basal extracellular glutamate (p<0.05 vs. poly I:C vehicle-treatment). Pretreatment with paliperidone and risperidone also prevented the acute MK-801-induced increase in extracellular glutamate. These observations demonstrate decreased NMDA receptor function and elevated extracellular glutamate, two key features of the NMDA glutamate receptor hypofunction model of schizophrenia, during periadolescence following prenatal immune activation. Treatment with the atypical antipsychotic medications paliperidone and risperidone normalized basal extracellular glutamate. Demonstration of glutamatergic abnormalities consistent with the NMDA glutamate receptor hypofunction model of schizophrenia as an early developmental consequence of prenatal immune action provides a model to identify novel early interventions targeting glutamatergic systems which play an important role in both positive and negative symptoms of schizophrenia." @default.
- W1998429087 created "2016-06-24" @default.
- W1998429087 creator A5000470136 @default.
- W1998429087 creator A5029513865 @default.
- W1998429087 creator A5050301357 @default.
- W1998429087 creator A5059560765 @default.
- W1998429087 creator A5070920757 @default.
- W1998429087 creator A5086869556 @default.
- W1998429087 creator A5088810304 @default.
- W1998429087 date "2011-08-01" @default.
- W1998429087 modified "2023-09-23" @default.
- W1998429087 title "Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801" @default.
- W1998429087 cites W1499413566 @default.
- W1998429087 cites W1602803263 @default.
- W1998429087 cites W17169411 @default.
- W1998429087 cites W1914381346 @default.
- W1998429087 cites W1964508173 @default.
- W1998429087 cites W1966934571 @default.
- W1998429087 cites W1973478979 @default.
- W1998429087 cites W1979532884 @default.
- W1998429087 cites W1982945842 @default.
- W1998429087 cites W1983141299 @default.
- W1998429087 cites W1983413649 @default.
- W1998429087 cites W1984715501 @default.
- W1998429087 cites W1987843838 @default.
- W1998429087 cites W1990999239 @default.
- W1998429087 cites W1994737820 @default.
- W1998429087 cites W2014608077 @default.
- W1998429087 cites W2019579307 @default.
- W1998429087 cites W2021706944 @default.
- W1998429087 cites W2022230955 @default.
- W1998429087 cites W2022654189 @default.
- W1998429087 cites W2022809683 @default.
- W1998429087 cites W2024267348 @default.
- W1998429087 cites W2024942419 @default.
- W1998429087 cites W2033880528 @default.
- W1998429087 cites W2034427457 @default.
- W1998429087 cites W2035009272 @default.
- W1998429087 cites W2040789766 @default.
- W1998429087 cites W2041408865 @default.
- W1998429087 cites W2050894512 @default.
- W1998429087 cites W2051643962 @default.
- W1998429087 cites W2061506085 @default.
- W1998429087 cites W2062224011 @default.
- W1998429087 cites W2066714452 @default.
- W1998429087 cites W2084299214 @default.
- W1998429087 cites W2084873146 @default.
- W1998429087 cites W2086425346 @default.
- W1998429087 cites W2091141323 @default.
- W1998429087 cites W2112218294 @default.
- W1998429087 cites W2138504515 @default.
- W1998429087 cites W2158137297 @default.
- W1998429087 doi "https://doi.org/10.1016/j.neulet.2011.06.011" @default.
- W1998429087 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3144266" @default.
- W1998429087 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21699956" @default.
- W1998429087 hasPublicationYear "2011" @default.
- W1998429087 type Work @default.
- W1998429087 sameAs 1998429087 @default.
- W1998429087 citedByCount "50" @default.
- W1998429087 countsByYear W19984290872012 @default.
- W1998429087 countsByYear W19984290872013 @default.
- W1998429087 countsByYear W19984290872014 @default.
- W1998429087 countsByYear W19984290872015 @default.
- W1998429087 countsByYear W19984290872016 @default.
- W1998429087 countsByYear W19984290872017 @default.
- W1998429087 countsByYear W19984290872018 @default.
- W1998429087 countsByYear W19984290872019 @default.
- W1998429087 countsByYear W19984290872020 @default.
- W1998429087 countsByYear W19984290872021 @default.
- W1998429087 countsByYear W19984290872022 @default.
- W1998429087 countsByYear W19984290872023 @default.
- W1998429087 crossrefType "journal-article" @default.
- W1998429087 hasAuthorship W1998429087A5000470136 @default.
- W1998429087 hasAuthorship W1998429087A5029513865 @default.
- W1998429087 hasAuthorship W1998429087A5050301357 @default.
- W1998429087 hasAuthorship W1998429087A5059560765 @default.
- W1998429087 hasAuthorship W1998429087A5070920757 @default.
- W1998429087 hasAuthorship W1998429087A5086869556 @default.
- W1998429087 hasAuthorship W1998429087A5088810304 @default.
- W1998429087 hasBestOaLocation W19984290872 @default.
- W1998429087 hasConcept C126322002 @default.
- W1998429087 hasConcept C134018914 @default.
- W1998429087 hasConcept C169760540 @default.
- W1998429087 hasConcept C169900460 @default.
- W1998429087 hasConcept C170493617 @default.
- W1998429087 hasConcept C185592680 @default.
- W1998429087 hasConcept C2781195155 @default.
- W1998429087 hasConcept C28406088 @default.
- W1998429087 hasConcept C55493867 @default.
- W1998429087 hasConcept C61174792 @default.
- W1998429087 hasConcept C67018056 @default.
- W1998429087 hasConcept C71924100 @default.
- W1998429087 hasConcept C86803240 @default.
- W1998429087 hasConceptScore W1998429087C126322002 @default.
- W1998429087 hasConceptScore W1998429087C134018914 @default.
- W1998429087 hasConceptScore W1998429087C169760540 @default.
- W1998429087 hasConceptScore W1998429087C169900460 @default.
- W1998429087 hasConceptScore W1998429087C170493617 @default.